Adhesive small bowel obstruction (aSBO) is a common cause of emergency surgical admission, and the optimal initial management between early surgery and conservative non-operative management (NOM) remains debated, particularly regarding recurrence and short-term safety. This systematic review aimed to evaluate short- and long-term outcomes of early operative management compared with conservative treatment for aSBO in adult and paediatric populations. A systematic search of MEDLINE, Embase, Scopus, and Cochrane CENTRAL was conducted from inception to 2025 in accordance with PRISMA guidelines. Nine studies were included. In stable adults, NOM was generally safe with comparable short-term complication and mortality rates to early surgery; however, prolonged delays following NOM failure were associated with increased morbidity and bowel resection. Long-term outcomes consistently favoured early operative management, demonstrating a 40-60% relative reduction in recurrence. Water-soluble contrast protocols improved diagnostic accuracy and NOM success, while specific radiological findings predicted failure. In paediatric patients, NOM was effective in many cases, but infants under one year of age had a higher likelihood of requiring surgery, and delays beyond 48 hours increased bowel resection rates. Overall, NOM is safe for selected patients, but early surgery offers superior long-term recurrence outcomes.
adhesive small bowel obstructionearly surgical interventionconservative treatmentrecurrence
Background: Fournier’s gangrene is a rapidly progressive infection requiring coordinated emergency diagnosis, resuscitation, antimicrobial treatment, and surgical source control. Early manifestations overlap with less severe perineal infections, creating substantial diagnostic uncertainty. This review examined diagnostic and management evidence relevant to emergency department practice. Methods: Publications available through 31/05/2026 were evaluated using an explicit clinical framework. Eleven original reports addressing imaging, prognostic assessment, surgical timing, antimicrobial duration, hyperbaric oxygen, wound management, and fecal diversion were summarized. Findings were synthesized narratively because study designs, treatment selection, and outcome definitions differed. Results: Computed tomography demonstrated anatomical disease extent, although imaging findings from confirmed cases did not establish diagnostic accuracy in unselected emergency populations. Prognostic scores identified physiological disturbance without replacing clinical assessment or operative diagnosis. Earlier debridement was associated with lower mortality, including mortality of 2.6% versus 27.7% for surgery within versus after twelve hours in one cohort. Shorter antimicrobial courses following source control were not associated with worse outcomes in a retrospective study. Hyperbaric oxygen, negative pressure wound therapy, and fecal diversion produced favorable findings in selected cohorts, with substantial uncertainty from nonrandom treatment allocation. Conclusions: Emergency management prioritizes early surgical involvement, immediate broad spectrum antimicrobials, physiological stabilization, and prompt debridement. Imaging and prognostic tools support decisions without postponing source control. Adjunctive interventions require individualized selection, while prospective comparative research remains essential for defining their benefits.
Fournier's gangreneperineal soft tissue infectionemergency department managementsurgical debridement
Background: Family physicians evaluate skin disorders associated with diagnostic delay, systemic deterioration, tissue destruction, or delayed cancer treatment. These presentations include suspected malignancy, severe drug reactions, and invasive infection, although their referral pathways differ, this review evaluated diagnostic and referral performance in these categories. Methods: Original studies published through 31 Jan 2026 were reviewed using predefined criteria. Patient-based investigations were separated from studies using standardized photographs or clinical vignettes, while cancer pathways were analyzed independently from same-day dermatologic emergencies. Results: Ten studies evaluated diagnostic classification, referral, excision decisions, or image-based recognition. Melanoma sensitivity in general practitioners was 29% in one comparative study, whereas another reported 66.7% sensitivity and 92.0% specificity for recognizing malignant lesions. Following training, dermoscopy increased referral sensitivity from 54.1% to 79.2% without reducing specificity. Sequential dermoscopy reduced excision or referral of suspicious lesions by 56.4%, whereas other diagnostic aids produced inconsistent effects. In an urgent-disease vignette study, family physicians recognized Stevens-Johnson syndrome in 71.4% and pemphigus vulgaris in 28.6% of responses. Conclusion: Diagnostic performance varied according to disease spectrum, clinical setting, physician experience, assessment method, and outcome definition. Training-supported dermoscopy improved selected cancer-triage outcomes, although benefits were not reproduced across all diagnostic technologies.
Laparoscopic sleeve gastrectomy (LSG) is the most frequently performed bariatric surgery. Although it is generally considered safe, a thorough preoperative assessment is essential to minimize the risk of complications. The need for histopathological examination of resected gastric specimens in bariatric surgery remains a subject of debate, particularly regarding the role of preoperative esophagogastroduodenoscopy (EGD). This study aimed to determine the prevalence of histopathological findings in resected specimens following sleeve gastrectomy and to assess their agreement with preoperative EGD findings at a tertiary center. This retrospective cross-sectional study examined patients who underwent LSG between 2009 to 2021. The data included demographics, comorbidities, preoperative EGD findings, and routine postoperative histopathology of the resected specimens. Diagnostic accuracy of preoperative EGD was assessed against resected-specimen histopathology. Among the 954 patients who underwent LSG, 67.1% were female, and 84.7% were Saudi nationals. Abnormal histopathological findings were observed in 45.5% (434/954) of the resected specimens, with gastritis being the predominant finding, present in 98.2% (426/434) of these. Preoperative EGD was performed in a subgroup of 357 patients (37.4%); in these, gastritis was the most prevalent EGD finding (50.1%). Helicobacter pylori was identified in 9.5% of patients who underwent preoperative EGD and in 8.0% of all resected specimens. Less common histopathological findings were metaplasia (0.6%), gastrointestinal stromal tumors (0.3%), gastric polyps (0.2%) and grade 1 gastric carcinoid (0.1%). Among the 357 patients who underwent preoperative EGD, sensitivity was 99.5%, specificity 98.3%, positive predictive value 98.4%, negative predictive value 99.4% and accuracy 98.9% against resected-specimen histopathology. Gastritis is the most prevalent histopathological finding in resected specimens following sleeve gastrectomy and on preoperative EGD, although significant pathologies are infrequent. In the selected subgroup of patients who underwent preoperative EGD, a normal EGD showed high agreement with normal histopathology of the resected specimen; these findings do not support omitting histopathological examination of resected specimens, and prospective multicenter studies are needed. Helicobacter pylori was frequently identified and was strongly associated with gastritis in unadjusted analyses; premalignant findings were too few to assess.
Background/Objectives: Children with Down syndrome are at increased risk of obstructive sleep apnea (OSA), which cannot be reliably excluded by symptoms or examination. Saudi evidence remains limited. This review synthesizes international and Saudi evidence and proposes a pediatric care pathway incorporating the transition to adult services. Methods: We conducted a structured narrative review of the English-language literature identified through PubMed/MEDLINE, selected journal websites, and reference lists. The review focused on publications from January 2018 to 17 September 2026, retaining relevant earlier studies. Evidence was synthesized qualitatively without a new meta-analysis or formal risk of bias assessment. Results: Published international estimates indicate that OSA affects approximately 50–79% of children with Down syndrome. American Academy of Pediatrics guidance recommends polysomnography (PSG) at ages 3–4 years regardless of symptoms, with earlier assessment when indicated. Nonrandomized infant intervention studies suggest potential benefits but do not establish an optimal universal screening schedule. Saudi evidence includes a small earlier PSG referral cohort and more recent caregiver surveys; no nationally representative PSG-confirmed prevalence study was identified. Arabic questionnaire validation in a mixed pediatric referral cohort does not establish Down syndrome-specific diagnostic accuracy. Published treatment evidence indicates that adenotonsillectomy often improves OSA, although residual disease commonly requires objective reassessment and individualized management. Conclusions: The evidence supports age-based PSG, earlier assessment when indicated, postoperative reassessment, and individualized multidisciplinary care. Building on this evidence, we propose a Saudi pathway linking referral tracking, family-centered positive airway pressure support, and coordinated transition. Regional networks and registry development remain unevaluated implementation proposals requiring stakeholder consultation, resource assessment, and pilot testing; they do not constitute an endorsed national guideline.
Down syndromeobstructive sleep apneasleep-disordered breathingpolysomnography screening
Saudi Journal of Otorhinolaryngology Head and Neck Surgery
Abstract Acute otitis media (AOM) represents a prevalent infection in children globally, leading to considerable morbidity and imposing a substantial burden on healthcare systems. Prompt and precise diagnosis is critical to reducing complications, such as tympanic membrane perforation, hearing impairment, and excessive antibiotic prescribing. Advances in artificial intelligence (AI), particularly deep learning, have created opportunities to enhance diagnostic accuracy and broaden access to care, especially in low-resource settings. This systematic review and meta-analysis aimed to evaluate the diagnostic performance of AI-based systems for detecting AOM compared with conventional clinical diagnosis and to analyze their accuracy relative to human clinicians across different model architectures and diagnostic methods. Following PRISMA-DTA standards and PROSPERO registration, systematic searches were conducted in PubMed, Web of Science, and IEEE Xplore up to July 30, 2025. Eligible studies included human participants with suspected AOM, employed AI-driven diagnostic approaches, and used a clinical reference standard. The Quality Assessment of Diagnostic Accuracy Studies-2 tool assessed bias, and pooled sensitivity and specificity were estimated using a bivariate random-effects model. Nine studies published between 2020 and 2025 met the inclusion criteria. The pooled sensitivity and specificity were 91% (95% confidence interval [CI]: 77%–97%) and 99% (95% CI: 94%–100%), respectively. AI models overall matched or outperformed general practitioners and pediatricians, approaching otolaryngologist-level accuracy. AI-based tools have the potential to improve AOM detection, mitigate inequalities in healthcare access, and promote more effective diagnosis, particularly in underserved regions.
OBJECTIVE: Aims of the study were to evaluate the diagnostic performance of abdominal ultrasonography, specifically its positive predictive value, in children younger than 36 months presenting with suspected intussusception to the emergency department of a major tertiary care center in Saudi Arabia and to describe the associated clinical and sonographic features. METHODS: This retrospective study reviewed the medical records and radiological findings of 150 pediatric patients aged less than 36 months who presented with suspected intussusception to the emergency department in a major tertiary care center in Saudi Arabia between 2005 and 2015. Ultrasound was used as the initial diagnostic modality, and findings were confirmed using contrast enema, computed tomography scan, or intraoperative findings when applicable. RESULTS: Out of 150 suspected cases, 36 patients (24.0%) were confirmed to have intussusception. All 36 ultrasound-positive cases were subsequently confirmed by contrast enema, computed tomography, or surgery, giving a positive predictive value of 100% (36/36). Because the 114 ultrasound-negative patients were classified on the basis of clinical course rather than an independent reference standard, sensitivity, specificity, and negative predictive value could not be validly estimated and are not reported. Vomiting and bloody stool were significantly associated with confirmed diagnosis; no significant association was found with gender. CONCLUSION: In this single-center retrospective cohort, a positive abdominal ultrasound reliably predicted confirmed intussusception, supporting its established role as the first-line imaging modality for suspected pediatric intussusception. Although these regional data add local confirmation but given the retrospective design and the absence of an independent reference standard for ultrasound-negative cases, they should be interpreted with caution.
Saudi Journal of Emergency Medicine · مجلد 7 (1S) · 91-91
Background: Acute heart failure diagnosis in emergency departments remains challenging despite multiple available diagnostic modalities. Current emergency evaluations rely variably on clinical assessment, biomarkers, and ultrasound techniques; however, their comparative diagnostic accuracy remains inadequately compared in previous studies. This systematic review and meta-analysis aim to evaluate the diagnostic accuracy of four categories of diagnostic approaches: Clinical Assessment, Biomarker Assessment, Basic Ultrasound Assessment, and Advanced Ultrasound Assessment for diagnosing acute heart failure in emergency settings. Methods: We conducted a literature review across PubMed/MEDLINE, Scopus, Google Scholar, Cochrane Library, Google Scholar, and Web of Science up to December 2024. Studies investigating the diagnostic modalities for acute heart failure in emergency settings with sufficient data to construct 2×2 contingency tables were included. Two independent reviewers performed screening, data extraction, and quality assessment using QUADAS-2. Diagnostic accuracy was synthesized using a bivariate random-effects model. Summary receiver operating characteristic (SROC) curves, pooled sensitivity, specificity, and area under the curve (AUC) were calculated with 95% confidence intervals (CI). Heterogeneity was assessed using I² statistics and publication bias with Deeks' funnel plot. Results: Thirty-three studies including a total of 17 participants to 1,586 participants met the inclusion criteria. Clinical Assessment demonstrated moderate diagnostic performance (AUC=0.591) with limited sensitivity (0.500, 95% CI: 0.484-0.515) but high specificity (0.858, 95% CI: 0.830-0.886). Biomarker Assessment showed excellent performance (AUC=0.906) with high sensitivity (0.874, 95% CI: 0.872-0.875) and good specificity (0.781, 95% CI: 0.778-0.783). Basic Ultrasound Assessment had moderate performance (AUC=0.750) with low sensitivity (0.349, 95% CI: 0.303-0.395) but high specificity (0.889, 95% CI: 0.874-0.904). Advanced Ultrasound Assessment demonstrated excellent performance (AUC=0.892) with good sensitivity (0.713, 95% CI: 0.705-0.720) and very high specificity (0.903, 95% CI: 0.900-0.905). All modalities showed remarkably consistent performance across studies (I²=0%). Conclusion: Biomarker Assessment provides the highest overall diagnostic accuracy for acute heart failure in emergency settings, while Advanced Ultrasound Assessment offers the optimal balance between sensitivity and specificity when equipment and expertise are available. Clinical Assessment alone has limitations for detecting acute heart failure but remains useful for exclusion. Our findings highly recommend adapting a multimodal diagnostic approach integrating biomarkers and advanced ultrasound techniques whenever possible for optimal diagnostic accuracy in emergency settings.
Differentiating between endodontic and non-endodontic sources of orofacial pain is a diagnostic challenge owing to overlapping clinical presentations. Artificial intelligence (AI) offers a potential solution to improve the diagnostic accuracy of endodontics by analysing complex clinical and radiographic data. To evaluate the performance of an artificial intelligence (AI) model in distinguishing endodontic pain from non-endodontic pain and compare its diagnostic accuracy, sensitivity, and specificity with those of an expert panel. This cross-sectional diagnostic study included 224 participants (134 with endodontic pain and 90 without endodontic pain). Clinical and radiographic data were analysed using a random forest AI model trained on features including radiographic lesions, pain characteristics, and pulp vitality tests. Model performance metrics, including accuracy, sensitivity, specificity, and the area under the receiver operating characteristic (ROC) curve (AUC-ROC), were assessed across the training, validation, and test datasets. The model’s performance was compared to that of an expert panel using statistical tests. The AI model demonstrated an overall diagnostic accuracy of 91.8% on the test set, with sensitivity and specificity of 92.1% and 91.4%, respectively. The AI model showed significantly higher sensitivity (p = 0.03) than the expert panel (accuracy: 89.2%). Feature importance analysis identified radiographic lesions (34%), pain characteristics (28%), and pulp vitality test results (25%) as the most influential predictors. The AI model exhibited superior diagnostic accuracy compared with the expert panel, indicating its potential as a reliable tool for differentiating endodontic pain from non-endodontic sources. Incorporating AI into clinical workflows can enhance diagnostic precision and improve patient outcomes in endodontics.
American Journal of Pediatrics · مجلد 12 (3) · 87-102
Background: Parapneumonic effusion (PPE) and empyema remain serious complications of childhood pneumonia associated with significant morbidity despite advances in antimicrobial therapy and surgical techniques. Accurate disease staging and timely stage-directed intervention are fundamental to optimal outcomes. Objective: To provide a current, evidence-based synthesis of the definition, etiology, diagnosis, and management of complicated pneumonia in children, with particular focus on areas of ongoing clinical controversy. Methods: A narrative review incorporating randomized controlled trials, systematic reviews, meta-analyses, Cochrane reviews, and international clinical guidelines published between 2016 and 2026 was conducted. PubMed was searched through May 2026 using terms including pneumonia, complicated pneumonia, parapneumonic effusion, empyema, VATS, fibrinolysis, decortication, and pediatric. Results: Chest radiography remains the initial imaging modality for suspected complicated pneumonia, with lateral decubitus views needed to assess pleural fluid mobility. However, chest ultrasonography is the preferred imaging modality for evaluating parapneumonic effusions and empyema because of its superior diagnostic accuracy, ability to characterize pleural collections, and absence of ionizing radiation. Management is stage-dependent, combining targeted antibiotic therapy with procedural intervention when indicated. Image-guided pigtail catheter drainage with intrapleural fibrinolytic therapy is effective for most patients. VATS demonstrates particular utility during the fibrinopurulent stage. No single fibrinolytic agent has demonstrated clear superiority; however, tissue plasminogen activator is most widely employed. Open decortication remains reserved for refractory or advanced-stage disease. Conclusion: Early diagnosis, appropriate antibiotics, and prompt intervention or surgery are all important for optimal care. The optimal outcomes require a multidisciplinary, individualized, stage-directed approach. Interventional radiology is appropriate for single loculations, while early VATS is favored for thick pleural rind or multiple loculations. Further high-quality prospective research is needed to establish definitive treatment algorithms.
International Journal of Molecular Sciences · مجلد 27 (12) · 5450-5450
Differentiating inflammatory bowel disease (IBD) from diarrhea-predominant irritable bowel syndrome (IBS-D) remains a major clinical challenge due to overlapping symptoms and the limited specificity of single biomarkers. A reliable, non-invasive multimarker approach is needed to improve diagnostic accuracy and reduce unnecessary endoscopic procedures. To evaluate the diagnostic performance of serum interleukin-17A (IL-17A), neutrophil-to-albumin ratio (NAR), and fecal calprotectin (FCP), individually and in combination, for discriminating IBD from IBS-D and healthy controls in Egyptian patients. In this case–control study, 300 participants (100 with IBD, 100 with IBS-D, and 100 healthy controls) were enrolled. Serum IL-17A, NAR, and FCP were measured, and subgroup analysis was performed for infected and non-infected IBS-D patients. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis, with optimal cutoffs determined by the Youden index. A combined biomarker model was constructed using logistic regression. All biomarkers demonstrated a significant stepwise increase from healthy controls to IBS-D and IBD (p < 0.001). IL-17A, NAR, and FCP were elevated in IBS-D compared with controls, indicating low-grade inflammation, but were highest in IBD. No significant differences were observed between infected and non-infected IBS-D patients. Among individual markers, NAR showed the highest diagnostic accuracy (AUC = 0.923), followed by FCP (AUC = 0.884) and IL-17A (AUC = 0.859). The combined model significantly improved performance (AUC = 0.973), achieving 89% sensitivity and 96% specificity. IBS-D is associated with measurable systemic and intestinal inflammation independent of infection status. The combined biomarker model integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising discriminatory performance for differentiating IBD from IBS-D. These findings suggest the potential applicability of combined non-invasive biomarkers in future diagnostic stratification approaches. However, the model was developed and evaluated within a single cohort, and external validation in independent populations is required before future potential clinical application. A multimarker diagnostic panel integrating IL-17A, neutrophil–albumin ratio, and fecal calprotectin demonstrated promising diagnostic performance for differentiating inflammatory bowel disease from IBS-D. The combined model may contribute to future diagnostic stratification strategies in patients with chronic diarrhea. However, these findings were derived from a single cohort and require validation in independent populations before broader clinical application.
inflammatory bowel diseasediarrhea-predominant irritable bowel syndromeIL-17Aneutrophil-to-albumin ratio
BACKGROUND: Whole-slide imaging (WSI) has shifted pathology toward digital workflows, creating the foundation for applying artificial intelligence (AI) to diagnostic tasks. This review summarises validated AI applications in diagnostic pathology, with an emphasis on clinical performance, regulatory developments and the practical barriers that affect implementation. METHODS: A structured search of PubMed, Scopus and Google Scholar identified English-language, peer-reviewed studies from January 2020 to May 2025. Eligible studies applied AI to diagnostic, grading or prognostic tasks in human tissue, used a pathologist-confirmed reference standard and included external or multi-centre validation. RESULTS: More than 150,000 digital slides were represented across the included studies. Reported performance metrics demonstrated strong diagnostic accuracy across several validated applications. Large meta-analyses and externally validated studies reported sensitivity values exceeding 96% and specificity above 93% for selected cancer-detection tasks, while other studies demonstrated high agreement for Gleason grading (QWK up to 0.862) and biomarker quantification (Ki-67 ICC 0.98). CONCLUSION: AI has the capacity to strengthen diagnostic pathology by improving consistency, measurement and efficiency. Moving from experimental use to routine reporting will require broad validation across centres, enhanced model transparency, strong quality-assurance systems and close cooperation between developers and pathologists.
BACKGROUND: Down syndrome (DS) is one of the most prevalent chromosomal abnormalities affecting global healthcare. Recent advances in artificial intelligence (AI) and machine learning (ML) have enhanced DS diagnostic accuracy. However, there is a lack of thorough evaluations analyzing the overall impact and effectiveness of AI-based DS diagnostic approaches. OBJECTIVES: This review intends to identify methodologies and technologies used in AI-driven DS diagnostics. It evaluates the performance of AI models in terms of standard evaluation metrics, highlighting their strengths and limitations. METHODOLOGY: In order to ensure transparency and rigor, the authors followed the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines. They extracted 1175 articles from major academic databases. By leveraging inclusion and exclusion criteria, a final set of 25 articles was selected. OUTCOMES: The findings revealed significant advancements in AI-powered DS diagnostics across diverse data modalities. The modalities, including facial images, ultrasound scans, and genetic data, demonstrated strong potential for early DS diagnosis. Despite these advancements, this review outlined the limitations of AI approaches. Small and imbalanced datasets reduce the generalizability of the AI models. The authors present actionable strategies to enhance the clinical adoptions of these models.
Down syndromeartificial intelligencemachine learningprenatal diagnosis
Agriculture sector is faced with perennial challenges that threaten both its productivity and sustainability. Among the greatest threats to cereal crops is disease, especially on cereal grains such as maize. Maize is an important grain that has grown globally, yet it often falls prey to maize leaf disease, a destructive and prevalent disorder. The consequences of these diseases go beyond individual farmers; reduced yields destabilize supply chains, market stability, and global efforts towards creating sustainable food systems. The prevalence of leaf diseases adversely affects crop productivity, which directly impacts the objective of sustainable agriculture. In order to address this problem, technology, more specifically artificial intelligence, has been a game-changer. Adopting cutting-edge research for maize disease detection not only raises diagnostic accuracy but also supports sustainable agricultural practices. This approach encourages effective input use, supports food security, minimizes environmental degradation, and provides farmers with accurate tools, all of which contribute to long-term agricultural resilience and sustainability. However, the incorporation of AI in farming is confronted by a number of challenges. Numerous hindrances hinder precise detection and categorization of maize leaf diseases via artificial intelligence methods. In tackling the limitations, the current study introduces an AI-based approach. It applied Multi-scaled Xception pre-trained models to extract deep features from images. The models were fine-tuned with varying weights for advancing the feature extraction so as to enhance the likelihood of correct visual classification. In addition to its strong accuracy, the research provides a formal and strict mathematical formulation, and different optimization methods further establish the effectiveness of the model. Additionally, the examination of fusion operators helps to improve the interpretability of the model. The expected model was tested with a confidence interval, showing that its performance remains within set limits.
BACKGROUND: Metabolic dysfunction-associated steatotic liver disease (MASLD), is a common liver disorder, predicted to increase globally. Currently, non-invasive methods are proposed for the assessment of (MASLD). This study aimed to investigate the use of serum Liver Type Fatty Acid Binding Protein (L-FABP) concentration as a diagnostic and prognostic biomarker in pediatric MASLD patients and to evaluate its relationship with steatosis and fibrosis. METHODS: An observational, cross-sectional study on paediatric MASLD patients. Serum levels of L-FABP and hepatic biochemical markers were measured and analyzed. Statistical analyses evaluated the association between L-FABP and other markers, while logistic regression and ROC curves assessed its diagnostic accuracy. RESULTS: Serum L-FABP levels showed a significant difference between the MASLD and control groups (P < 0.0001). The results of logistic regression revealed that each one-unit elevation of L-FABP level was associated with 144.5% higher odds of being MASLD (95% CI: 129.3% - 167.8%). A receiver operating characteristics (ROC) curve was constructed to assess the diagnostic accuracy of L-FABP. The resulted area under the ROC curve (AUC) was 0.885. The cutoff value was 5.7 ng/ mL, with sensitivity of 72.73%, and a specificity of 93.62%. The results also showed that the odds ratio of progressing from stage F2 to F3 increases by 108.9% (95% CI: 87.2% - 141.4%) for each one-unit increase in serum L-FABP level. CONCLUSION: L-FABP shows promise as a non-invasive biomarker for diagnosing and monitoring MASLD in pediatric patients. Its association with disease stages suggests its utility in assessing disease progression, particularly in advanced stages.